At the gold-solution boundary, an applied potential drives electron-transfer behavior that can be recorded as current or impedance. Charged species interacting with the interface change this electrochemical response, so the measured signal reflects changes occurring at the sensing surface. This interfacial mechanism allows binding events to be converted into an electrical readout for biosensing.
Chemical modification determines what the surface can recognize. Antibodies, antigens, nucleic acids, or other recognition molecules can be bound to gold so that a target pathogen or biomarker is captured near the electrode. Capture changes the local interfacial environment and therefore the current or impedance, linking molecular recognition to a measurable electrochemical signal.
Label-free formats measure the electrochemical consequence of capture directly rather than relying on an added detection label. This can reduce processing between sample exposure and readout, while minimally processed formats retain a simplified workflow without requiring a fully label-free design. For infection and immune studies, these approaches support rapid measurement through changes at the functionalized interface.
Gold's high conductivity supports efficient electrical communication at the sensing interface, while its stability helps maintain that interface during measurement. Chemical modification adds a second capability: the same surface can be equipped with recognition molecules that bind selected targets. Combining electrical performance with surface functionalization makes gold electrodes useful when molecular capture must produce a measurable signal.
A basic workflow for gold electrodes begins by preparing a sensing surface and chemically attaching a recognition molecule suited to the target. The surface is then exposed to a sample containing a possible pathogen or biomarker, followed by electrochemical measurement. Investigators compare the resulting current or impedance with the interface's response to determine whether target capture altered the signal.
In infection research, gold electrodes can be configured to capture pathogens directly or detect pathogen-associated nucleic acids and biomarkers. In immunology, antibody- or antigen-based interfaces can be used to monitor immune signals. The same electrical readout supports rapid diagnostic platform development, especially when minimizing labels or sample-processing steps is important.
Measurements of current and impedance show whether target interaction has changed electron transfer or other interfacial behavior. However, the electrical response alone does not identify the captured target; that specificity comes from the antibody, antigen, nucleic acid, or other recognition molecule placed on the surface. Interpretation therefore requires considering both the measured signal and the recognition chemistry used.